Darwin Global Management »

Avidity Biosciences Ord shares owned by Darwin Global Management

Quarter-by-quarter ownership of Avidity Biosciences Ord (RNA) shares owned by Darwin Global Management from 13F filings

Historical chart of Darwin Global Management investment in Avidity Biosciences Ord

Tip: Access up to 7 years of quarterly data

All positions including Avidity Biosciences Ord held by Darwin Global Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Avidity Biosciences Ord by Darwin Global Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $8.1M 200k 40.54

More positions owned by Darwin Global Management

Cytokinetics Com New (CYTK)
Insmed Com Par $.01 (INSM)
Vaxcyte (PCVX)
Geron Corporation (GERN)
Keros Therapeutics (KROS)
Corbus Pharmaceuticals Hldgs Com New (CRBP)
Spyre Therapeutics Com New (SYRE)
Avidity Biosciences Ord (RNA)
Elevation Oncology (ELEV)

View all positions for Darwin Global Management

Top funds holding Avidity Biosciences Ord

FMR
T. Rowe Price Associates
BlackRock
Rtw Investments
Vanguard Group
venBio Select Advisor
RA Capital Management
Cowen And Company
Henderson Group
State Street Corporation
Adage Capital Partners GP
Geode Capital Management
Casdin Capital
Artisan Partners Limited Partnership
Boxer Capital

View all funds holding Avidity Biosciences Ord